Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.

Kaiyang LiKenneth TanAlexandra YacovelliWei Guang Bi

Published in: Journal of oral rehabilitation (2023)

BTX-A is a safe and effective treatment for reducing pain and improving temporomandibular muscle and joint function in muscular TMD patients. A bilateral dose of 60-100 U might be an optimal choice for treating muscular TMD pain.

Keyphrases

botulinum toxin
chronic pain
end stage renal disease
resistance training
pain management
neuropathic pain
ejection fraction
newly diagnosed
chronic kidney disease
skeletal muscle
peritoneal dialysis
high intensity
postoperative pain
patient reported
decision making